AMI-463

N/A

Report date: 2024/05/13 10:59:26
NMEFirst In Class

Base Information

Drug NameAMI-463
Drug Alias NameAMI-463AMI463
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell Adhesion Associated, Oncogene Regulated inhibitors
TargetsCell Adhesion Associated, Oncogene Regulated
Therapy Area/IndicationsSarcomaRhabdomyosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmira Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesAmira Therapeutics SL
Inactive CompaniesN/A
Active IndicationsSarcomaRhabdomyosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A